Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The genome sequence of the bloodfluke planorb, <i>Biomphalaria glabrata</i> NIMR strain (Say, 1818).

Wellcome open research·2026
Same author

TRPtracker: a community database for monitoring praziquantel sensitivity at TRPM<sub>PZQ</sub> variants.

International journal for parasitology. Drugs and drug resistance·2026
Same author

Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complement.

NPJ vaccines·2025
Same author

Fexinidazole and Corallopyronin A target Wolbachia-infected sheath cells present in filarial nematodes.

PLoS pathogens·2025
Same author

TRPtracker: a community database for monitoring praziquantel sensitivity at TRPM<sub>PZQ</sub> variants.

bioRxiv : the preprint server for biology·2025
Same author

Hybrid reference genome assemblies for <i>Leishmania (Viannia) braziliensis</i>, a primary agent of mucocutaneous leishmaniasis.

Microbiology resource announcements·2025

Related Experiment Video

Updated: May 13, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
06:40

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Genomics and emerging drug discovery technologies.

Matthew Berriman1, Sara Lustigman, James P McCarter

  • 1Wellcome Trust Sanger Institute, Pathogen Sequencing Unit, Wellcome Trust Genome Campus, Hinxton, CB10 1SA, UK.

Expert Opinion on Drug Discovery
|March 16, 2013
PubMed
Summary

The genomics era is here for helminth research, with many genomes expected soon. This will aid drug discovery and control strategies, despite technical challenges in sequencing and annotation.

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Experiment Videos

Last Updated: May 13, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
06:40

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Area of Science:

  • Parasitology
  • Genomics
  • Drug Discovery

Background:

  • The study of helminths is rapidly advancing into the genomics era.
  • Improving sequencing technologies and decreasing costs are making genomes more accessible.
  • Parasitologists and drug discovery researchers will soon consider genomic data standard for organisms of interest.

Purpose of the Study:

  • To highlight the impending availability of numerous helminth genomes (nematodes and platyhelminths).
  • To address the inherent challenges in helminth genome assembly and annotation.
  • To outline the necessary adaptations in parasitology research programs for effective genomic data utilization.

Main Methods:

  • Genome sequencing of helminth species.
  • Bioinformatic approaches for assembly and annotation.
  • Application of genomic information for control strategies and drug development.

Main Results:

  • Anticipation of draft or complete genomes for approximately 100 nematode and platyhelminth species within a decade.
  • Identification of challenges including genome size, repetitive elements, gene structure, and sequence polymorphisms.
  • Recognition of immediate applications in gene and protein expression/function analysis via microarrays, proteomics, and RNA interference.

Conclusions:

  • Helminth genomics presents significant opportunities for advancing parasitology and drug discovery.
  • Adaptation of research programs is crucial to leverage genomic data for developing effective control strategies, including new anthelmintics.
  • Genomic information will revolutionize our understanding of helminth biology and facilitate the development of novel interventions.